Barbara Caulfield has resigned her role as executive VP and general counsel at Affymetrix and will leave the company on June 13 to take a position with a private law firm, according to a US Securities and Exchange Commission document. She will continue to serve as secretary to the company’s board of directors.
Â
Caulfield is taking members of her legal team from Affymetrix with her to the Dewey LeBoeuf law firm.Â
Â
Joining Caulfield in the East Palo Alto, Calif., office of the New York-based law firm are Michael Malacek and Peter Root as partners, and Stephen Holmes as counsel.
Â
Â
The US Centers for Disease Control and Prevention has added five new members to its genomics working group. The Evaluation of Genomic Applications in Practice and Prevention Working Group includes specialists in genomics, healthcare, clinical and laboratory practice, ethics, epidemiology, public health, healthcare, and other related areas.
Â
The latest additions to the EGAPP working group include: Doug Campos-Outcalt of the University of Arizona’s College of Medicine; Roger Klein of the H. Lee Moffitt Cancer Center & Research Institute, and the University of South Florida College of Medicine; Kenneth Offit of Memorial Sloan-Kettering Cancer Center; Stephen Pauker of Tufts Medical Center; and David Veenstra of the University of Washington.
Â
Leaving the EGAPP working group are Katrina Armstrong of the University of Pennsylvania’s School of Medicine, and Kathryn Phillips of the University of California San Francisco.